BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 28024184)

  • 1. Serpinb9 is a marker of antigen cross-presenting dendritic cells.
    Mangan MS; Vega-Ramos J; Joeckel LT; Mitchell AJ; Rizzitelli A; Roediger B; Kaiserman D; Weninger WW; Villadangos JA; Bird PI
    Mol Immunol; 2017 Feb; 82():50-56. PubMed ID: 28024184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serpinb9 (Spi6)-deficient mice are impaired in dendritic cell-mediated antigen cross-presentation.
    Rizzitelli A; Meuter S; Vega Ramos J; Bird CH; Mintern JD; Mangan MS; Villadangos J; Bird PI
    Immunol Cell Biol; 2012 Oct; 90(9):841-51. PubMed ID: 22801574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of the cross-presenting dendritic cell subsets in the skin-draining lymph node.
    Kitano M; Yamazaki C; Takumi A; Ikeno T; Hemmi H; Takahashi N; Shimizu K; Fraser SE; Hoshino K; Kaisho T; Okada T
    Proc Natl Acad Sci U S A; 2016 Jan; 113(4):1044-9. PubMed ID: 26755602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Serpin Regulatory Mechanism: SerpinB9 IS REVERSIBLY INHIBITED BY VICINAL DISULFIDE BOND FORMATION IN THE REACTIVE CENTER LOOP.
    Mangan MS; Bird CH; Kaiserman D; Matthews AY; Hitchen C; Steer DL; Thompson PE; Bird PI
    J Biol Chem; 2016 Feb; 291(7):3626-38. PubMed ID: 26670609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical roles of a dendritic cell subset expressing a chemokine receptor, XCR1.
    Yamazaki C; Sugiyama M; Ohta T; Hemmi H; Hamada E; Sasaki I; Fukuda Y; Yano T; Nobuoka M; Hirashima T; Iizuka A; Sato K; Tanaka T; Hoshino K; Kaisho T
    J Immunol; 2013 Jun; 190(12):6071-82. PubMed ID: 23670193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serine protease inhibitor 6 is required to protect dendritic cells from the kiss of death.
    Lovo E; Zhang M; Wang L; Ashton-Rickardt PG
    J Immunol; 2012 Feb; 188(3):1057-63. PubMed ID: 22227570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The granzyme B-Serpinb9 axis controls the fate of lymphocytes after lysosomal stress.
    Bird CH; Christensen ME; Mangan MS; Prakash MD; Sedelies KA; Smyth MJ; Harper I; Waterhouse NJ; Bird PI
    Cell Death Differ; 2014 Jun; 21(6):876-87. PubMed ID: 24488096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The acquisition of antigen cross-presentation function by newly formed dendritic cells.
    Sathe P; Pooley J; Vremec D; Mintern J; Jin JO; Wu L; Kwak JY; Villadangos JA; Shortman K
    J Immunol; 2011 May; 186(9):5184-92. PubMed ID: 21422244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serine protease inhibitor 6 plays a critical role in protecting murine granzyme B-producing regulatory T cells.
    Azzi J; Skartsis N; Mounayar M; Magee CN; Batal I; Ting C; Moore R; Riella LV; Ohori S; Abdoli R; Smith B; Fiorina P; Heathcote D; Bakhos T; Ashton-Rickardt PG; Abdi R
    J Immunol; 2013 Sep; 191(5):2319-27. PubMed ID: 23913965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting edge: limited specialization of dendritic cell subsets for MHC class II-associated presentation of viral particles.
    Keller SA; Bauer M; Manolova V; Muntwiler S; Saudan P; Bachmann MF
    J Immunol; 2010 Jan; 184(1):26-9. PubMed ID: 19949081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses.
    Silva M; Silva Z; Marques G; Ferro T; Gonçalves M; Monteiro M; van Vliet SJ; Mohr E; Lino AC; Fernandes AR; Lima FA; van Kooyk Y; Matos T; Tadokoro CE; Videira PA
    Oncotarget; 2016 Jul; 7(27):41053-41066. PubMed ID: 27203391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like Receptor 4 Engagement on Dendritic Cells Restrains Phago-Lysosome Fusion and Promotes Cross-Presentation of Antigens.
    Alloatti A; Kotsias F; Pauwels AM; Carpier JM; Jouve M; Timmerman E; Pace L; Vargas P; Maurin M; Gehrmann U; Joannas L; Vivar OI; Lennon-Duménil AM; Savina A; Gevaert K; Beyaert R; Hoffmann E; Amigorena S
    Immunity; 2015 Dec; 43(6):1087-100. PubMed ID: 26682983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG promotes cross-presentation of dead cell-associated antigens by pre-CD8α+ dendritic cells [corrected].
    de Brito C; Tomkowiak M; Ghittoni R; Caux C; Leverrier Y; Marvel J
    J Immunol; 2011 Feb; 186(3):1503-11. PubMed ID: 21187449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroma-dependent development of two dendritic-like cell types with distinct antigen presenting capability.
    Periasamy P; O'Neill HC
    Exp Hematol; 2013 Mar; 41(3):281-92. PubMed ID: 23178375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-mediated targeting of antigen to C-type lectin-like receptors Clec9A and Clec12A elicits different vaccination outcomes.
    Macri C; Dumont C; Panozza S; Lahoud MH; Caminschi I; Villadangos JA; Johnston AP; Mintern JD
    Mol Immunol; 2017 Jan; 81():143-150. PubMed ID: 27978488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pro-survival role for the intracellular granzyme B inhibitor Serpinb9 in natural killer cells during poxvirus infection.
    Mangan MS; Melo-Silva CR; Luu J; Bird CH; Koskinen A; Rizzitelli A; Prakash M; Scarff KL; Müllbacher A; Regner M; Bird PI
    Immunol Cell Biol; 2017 Nov; 95(10):884-894. PubMed ID: 28722018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8- dendritic cells and macrophages cross-present poly(D,L-lactate-co-glycolate) acid microsphere-encapsulated antigen in vivo.
    Schliehe C; Redaelli C; Engelhardt S; Fehlings M; Mueller M; van Rooijen N; Thiry M; Hildner K; Weller H; Groettrup M
    J Immunol; 2011 Sep; 187(5):2112-21. PubMed ID: 21795597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of DC Functions Using CD205-DTR Knock-In Mice.
    Fukaya T; Takagi H; Uto T; Arimura K; Sato K
    Methods Mol Biol; 2016; 1423():291-308. PubMed ID: 27142025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR3-Mediated CD8+ Dendritic Cell Activation Is Coupled with Establishment of a Cell-Intrinsic Antiviral State.
    Széles L; Meissner F; Dunand-Sauthier I; Thelemann C; Hersch M; Singovski S; Haller S; Gobet F; Fuertes Marraco SA; Mann M; Garcin D; Acha-Orbea H; Reith W
    J Immunol; 2015 Aug; 195(3):1025-33. PubMed ID: 26101320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy.
    Jiang L; Wang YJ; Zhao J; Uehara M; Hou Q; Kasinath V; Ichimura T; Banouni N; Dai L; Li X; Greiner DL; Shultz LD; Zhang X; Sun ZJ; Curtin I; Vangos NE; Yeoh ZC; Geffken EA; Seo HS; Liu ZX; Heffron GJ; Shah K; Dhe-Paganon S; Abdi R
    Cell; 2020 Nov; 183(5):1219-1233.e18. PubMed ID: 33242418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.